MEDICLINIC INTERNATIONAL LIMITED - Disclosure of changes in beneficial interest

Disclosure of changes in beneficial interest

Mediclinic International Limited

(Incorporated in the Republic of South Africa)

(Registration number: 1983/010725/06)

ISIN: ZAE000074142

Share Code: MDC

(“Mediclinic” or “the company”)



DISCLOSURE OF CHANGES IN BENEFICIAL INTEREST



In accordance with the JSE Limited Listings Requirements and

section 122(1) of the Companies Act, 71 of 2008, as amended,

shareholders are advised that the Public Investment Corporation

(SOC) Limited, informed the company on 26 November 2013 that it

acquired Mediclinic ordinary shares increasing its interest from

9.997% to 10.055% in the issued shares of Mediclinic.



Stellenbosch

27 November 2013



Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa

PO Box 456, Stellenbosch 7599, South Africa

Tel +27 (0)21 809 6500

Fax +27 (0)21 886 4037

Ethics Line: 0800 005 316

Website: www.mediclinic.com



Sponsor

RAND MERCHANT BANK (a division of FirstRand Bank Limited)


Date: 27/11/2013 09:44:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.